12 HR ranolazine 1000 MG Extended Release Oral Tablet — RxCUI 728231
RxNorm drug concept · Semantic clinical drug
RxCUI 728231
Semantic clinical drug · SCD
● Current RxNorm concept 46 FDA products
101 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI728231
Official name12 HR ranolazine 1000 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asranolazine 1000 MG 12HR Extended Release Oral Tablet
FDA products mapped46
Package NDCs mapped101
Reported Medicaid activity (SDUD)134,609 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Ranolazine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Ranolazine is specifically for chronic angina — the recurring chest pain or tightness you get when your heart isn't getting enough blood flow. It's not a heart attack treatment or...
- What exactly is ranolazine supposed to do for me?
- If you're taking the extended-release tablet (Ranexa or generic ranolazine), you can take it with or without food — your choice. The important thing is to swallow it whole. Never c...
- Do I have to take this with food? And can I split the tablet?
🕸️ Concept Web — How 12 HR ranolazine 1000 MG Extended Release Oral T... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
12 HR ranolazine 1000 MG Extended Release Oral Tablet
RxCUI 728231 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Ranolazine
35829IN
-
Ranolazine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Ranexa
356778BN
-
Ranexa
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ranolazine Extended Release Oral Tablet
616491SCDF -
Ranolazine Oral Product
1157902SCDG -
Ranolazine Pill
1157903SCDG -
Ranolazine Extended Release Oral Tablet [Ranexa]
616494SBDF -
Ranexa Oral Product
1177693SBDG -
Ranexa Pill
1177694SBDG -
Extended Release Oral Tablet
316945DF -
Oral Product
1151131DFG - +1 more in this family
-
Ranolazine Extended Release Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ranolazine 1000 MG
727656SCDC -
12 HR ranolazine 1000 MG Extended Release Oral Tablet [Ranexa]
860737SBD -
Ranolazine 1000 MG [Ranexa]
727658SBDC
-
Ranolazine 1000 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Ranolazine 1000 MG
SCDC · 727656 -
Ranolazine Extended Release Oral Tablet
SCDF · 616491 -
Ranolazine Oral Product
SCDG · 1157902 -
Ranolazine Pill
SCDG · 1157903
Brand-Name Concepts
-
12 HR ranolazine 1000 MG Extended Release Oral Tablet [Ranexa]
SBD · 860737 -
Ranolazine 1000 MG [Ranexa]
SBDC · 727658 -
Ranolazine Extended Release Oral Tablet [Ranexa]
SBDF · 616494 -
Ranexa Oral Product
SBDG · 1177693 -
Ranexa Pill
SBDG · 1177694 -
Ranexa
BN · 356778
📦 FDA Products & Package NDCs
46 products · 101 package NDCs
101 package NDCs map to RxCUI 728231 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 13668-0759-60 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTI... | Ranolazine | Torrent Pharma, Inc. | 2026-05-11 |
| 13668-0760-60 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTI... | Ranolazine | Torrent Pharma, Inc. | 2026-05-11 |
| 27241-0125-02 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-125-02) | Ranolazine | Ajanta Pharma USA Inc. | 2019-08-23 |
| 27241-0125-05 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-125-05) | Ranolazine | Ajanta Pharma USA Inc. | 2021-07-14 |
| 27241-0126-02 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-126-02) | Ranolazine | Ajanta Pharma USA Inc. | 2019-08-23 |
| 27241-0126-05 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-126-05) | Ranolazine | Ajanta Pharma USA Inc. | 2021-07-14 |
| 29300-0296-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLAST... | Ranolazine | Unichem Pharmaceuticals (USA), Inc. | 2023-07-15 |
| 29300-0296-05 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLAST... | Ranolazine | Unichem Pharmaceuticals (USA), Inc. | 2023-07-15 |
| 29300-0296-16 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTI... | Ranolazine | Unichem Pharmaceuticals (USA), Inc. | 2023-07-15 |
| 29300-0297-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLAST... | Ranolazine | Unichem Pharmaceuticals (USA), Inc. | 2023-07-15 |
| 29300-0297-16 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTI... | Ranolazine | Unichem Pharmaceuticals (USA), Inc. | 2023-07-15 |
| 29300-0297-52 | 250 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLAST... | Ranolazine | Unichem Pharmaceuticals (USA), Inc. | 2023-07-15 |
| 31722-0668-60 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (31722-... | Ranolazine | Camber Pharmaceuticals, Inc. | 2022-05-05 |
| 31722-0669-60 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (31722-... | Ranolazine | Camber Pharmaceuticals, Inc. | 2022-05-05 |
| 42291-0773-60 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (42291-... | Ranolazine | AvKARE | 2020-10-27 |
| 42291-0774-60 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (42291-... | Ranolazine | AvKARE | 2020-10-27 |
| 42571-0324-05 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (42571-324-05) | Ranolazine | Micro Labs Limited | 2020-06-01 |
| 42571-0324-11 | 100 BLISTER PACK in 1 CARTON (42571-324-11) / 10 TABLET, EX... | Ranolazine | Micro Labs Limited | 2020-06-01 |
| 42571-0324-60 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (42571-324-60) | Ranolazine | Micro Labs Limited | 2020-06-01 |
| 42571-0324-64 | 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (42571-324-64) | Ranolazine | Micro Labs Limited | 2020-06-01 |
| 42571-0325-11 | 100 BLISTER PACK in 1 CARTON (42571-325-11) / 10 TABLET, EX... | Ranolazine | Micro Labs Limited | 2020-06-01 |
| 42571-0325-60 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (42571-325-60) | Ranolazine | Micro Labs Limited | 2020-06-01 |
| 42571-0325-64 | 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (42571-325-64) | Ranolazine | Micro Labs Limited | 2020-06-01 |
| 50228-0423-05 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 PACKAGE (5022... | RANOLAZINE | ScieGen Pharmaceuticals, Inc | 2019-06-04 |
| 50228-0423-30 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 PACKAGE (50228... | RANOLAZINE | ScieGen Pharmaceuticals, Inc | 2019-06-04 |
| 50228-0423-60 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 PACKAGE (50228... | RANOLAZINE | ScieGen Pharmaceuticals, Inc | 2019-06-04 |
| 50228-0424-05 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 PACKAGE (5022... | RANOLAZINE | ScieGen Pharmaceuticals, Inc | 2019-06-04 |
| 50228-0424-30 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 PACKAGE (50228... | RANOLAZINE | ScieGen Pharmaceuticals, Inc | 2019-06-04 |
| 50228-0424-60 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 PACKAGE (50228... | RANOLAZINE | ScieGen Pharmaceuticals, Inc | 2019-06-04 |
| 50268-0722-15 | 50 BLISTER PACK in 1 BOX (50268-722-15) / 1 TABLET, FILM CO... | Ranolazine | AvPAK | 2022-09-20 |
| 50268-0723-13 | 30 BLISTER PACK in 1 BOX (50268-723-13) / 1 TABLET, FILM CO... | Ranolazine | AvPAK | 2022-09-20 |
| 59651-0009-18 | 180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651... | Ranolazine | Aurobindo Pharma Limited | 2022-12-23 |
| 59651-0009-60 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-... | Ranolazine | Aurobindo Pharma Limited | 2022-12-23 |
| 59651-0009-99 | 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (5965... | Ranolazine | Aurobindo Pharma Limited | 2022-12-23 |
| 59651-0010-18 | 180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651... | Ranolazine | Aurobindo Pharma Limited | 2022-12-23 |
| 59651-0010-60 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-... | Ranolazine | Aurobindo Pharma Limited | 2022-12-23 |
| 59651-0010-99 | 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (5965... | Ranolazine | Aurobindo Pharma Limited | 2022-12-23 |
| 63304-0017-05 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-017-05) | Ranolazine | Sun Pharmaceutical Industries, Inc. | 2019-05-28 |
| 63304-0017-28 | 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-017-28) | Ranolazine | Sun Pharmaceutical Industries, Inc. | 2019-05-28 |
| 63304-0017-60 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-017-60) | Ranolazine | Sun Pharmaceutical Industries, Inc. | 2019-05-28 |
| 63304-0018-05 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-018-05) | Ranolazine | Sun Pharmaceutical Industries, Inc. | 2019-05-28 |
| 63304-0018-28 | 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-018-28) | Ranolazine | Sun Pharmaceutical Industries, Inc. | 2019-05-28 |
| 63304-0018-60 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-018-60) | Ranolazine | Sun Pharmaceutical Industries, Inc. | 2019-05-28 |
| 67877-0525-10 | 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (6787... | Ranolazine | Ascend Laboratories, LLC | 2020-12-02 |
| 67877-0525-38 | 10 BLISTER PACK in 1 CARTON (67877-525-38) / 10 TABLET, FIL... | Ranolazine | Ascend Laboratories, LLC | 2020-12-02 |
| 67877-0525-60 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67877-... | Ranolazine | Ascend Laboratories, LLC | 2020-12-02 |
| 67877-0526-05 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67877... | Ranolazine | Ascend Laboratories, LLC | 2020-12-02 |
| 67877-0526-38 | 10 BLISTER PACK in 1 CARTON (67877-526-38) / 10 TABLET, FIL... | Ranolazine | Ascend Laboratories, LLC | 2020-12-02 |
| 67877-0526-60 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67877-... | Ranolazine | Ascend Laboratories, LLC | 2020-12-02 |
| 68462-0319-05 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462... | Ranolazine | Glenmark Pharmaceuticals Inc., USA | 2019-07-05 |
Observed labelers:
Proficient Rx LP (14) ·
Viona Pharmaceuticals Inc (8) ·
Zydus Lifesciences Limited (8) ·
Micro Labs Limited (7) ·
Ascend Laboratories, LLC (6) ·
Aurobindo Pharma Limited (6)
· +17 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.